2025-01-09 2026-03-31 2026-03-31 false 16173621 Enticeable Consulting Ltd 63110Data processing, hosting and related activities iso4217:GBP xbrli:pure 161736212025-01-09 161736212026-03-31 161736212025-01-09 2026-03-31 16173621bus:SmallEntities2025-01-09 2026-03-31 16173621bus:AuditExempt-NoAccountantsReport2025-01-09 2026-03-31 16173621bus:FullAccounts2025-01-09 2026-03-31 16173621core:WithinOneYear2026-03-31 16173621core:AfterOneYear2026-03-31 16173621core:WithinOneYear2025-01-09 2026-03-31 16173621core:AfterOneYear2025-01-09 2026-03-31 16173621core:CurrentFinancialInstruments2026-03-31 16173621core:Non-currentFinancialInstruments2026-03-31 16173621core:CurrentFinancialInstruments2025-01-09 2026-03-31 16173621core:Non-currentFinancialInstruments2025-01-09 2026-03-31 16173621core:LandBuildings2025-01-09 2026-03-31 16173621core:FurnitureFittings2025-01-09 2026-03-31 16173621core:OfficeEquipment2025-01-09 2026-03-31 16173621core:Vehicles2025-01-09 2026-03-31 16173621core:PlantMachinery2025-01-09 2026-03-31 16173621core:OtherPropertyPlantEquipment2025-01-09 2026-03-31 16173621core:LandBuildings2026-03-31 16173621core:PlantMachinery2026-03-31 16173621core:Vehicles2026-03-31 16173621core:FurnitureFittings2026-03-31 16173621core:OfficeEquipment2026-03-31 16173621core:OtherPropertyPlantEquipment2026-03-31 16173621core:Right-of-useAssets2025-01-09 2026-03-31 16173621core:Right-of-useAssets2026-03-31 16173621core:Goodwill2025-01-09 2026-03-31 16173621core:PatentsTrademarksLicencesConcessionsSimilar2025-01-09 2026-03-31 16173621core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-01-09 2026-03-31 16173621core:OtherResidualIntangibleAssets2025-01-09 2026-03-31 16173621core:Goodwill2026-03-31 16173621core:DevelopmentCostsCapitalisedDevelopmentExpenditure2026-03-31 16173621core:PatentsTrademarksLicencesConcessionsSimilar2026-03-31 16173621core:OtherResidualIntangibleAssets2026-03-31 16173621dpl:CostSales2025-01-09 2026-03-31 16173621dpl:AdministrativeExpenses2025-01-09 2026-03-31 16173621dpl:DistributionCosts2025-01-09 2026-03-3116173621core:ShareCapital2026-03-31 16173621core:SharePremium2026-03-31 16173621core:RevaluationReserve2026-03-31 16173621core:OtherReservesSubtotal2026-03-31 16173621core:ShareCapitalPreferenceShares2026-03-31 16173621core:CapitalRedemptionReserve2026-03-31 16173621core:OtherCapitalReserve2026-03-31 16173621core:RetainedEarningsAccumulatedLosses2026-03-3116173621core:ShareCapital2025-01-09 2026-03-31 16173621core:SharePremium2025-01-09 2026-03-31 16173621core:RevaluationReserve2025-01-09 2026-03-31 16173621core:OtherReservesSubtotal2025-01-09 2026-03-31 16173621core:RetainedEarningsAccumulatedLosses2025-01-09 2026-03-311617362112025-01-09 2026-03-31 1617362122025-01-09 2026-03-3116173621core:ShareCapital12025-01-09 2026-03-31 16173621core:ShareCapital22025-01-09 2026-03-3116173621core:SharePremium12025-01-09 2026-03-31 16173621core:SharePremium22025-01-09 2026-03-3116173621core:RevaluationReserve12025-01-09 2026-03-31 16173621core:RevaluationReserve22025-01-09 2026-03-3116173621core:RetainedEarningsAccumulatedLosses12025-01-09 2026-03-31 16173621core:RetainedEarningsAccumulatedLosses22025-01-09 2026-03-311617362112025-01-09 2026-03-3116173621core:Non-currentFinancialInstrumentscore:CostValuation2025-01-09 16173621core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-31 16173621core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3116173621core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-31 16173621core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2026-03-31 16173621core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3116173621core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-01-09 16173621core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-31 16173621core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-31 16173621core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-31 16173621core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2026-03-31 16173621core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-31 16173621core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2026-03-3116173621core:Non-currentFinancialInstruments2026-03-31 16173621core:Non-currentFinancialInstruments2025-01-0816173621bus:Director12025-01-09 2026-03-3116173621bus:Director22025-01-09 2026-03-3116173621bus:Director32025-01-09 2026-03-3116173621bus:PrivateLimitedCompanyLtd2025-01-09 2026-03-31
Enticeable Consulting Ltd
Unaudited Financial Statements
for the period ended 31 March 2026
Company registration number 16173621
(England and Wales)

Company Information

For the period 9 January 2025 to 31 March 2026
Directors Walsh-Waring, Emma Katherine
Clarkin, Nicholas Charles Graham
Jasharaj, Sildi

Registered office Hosehill Farm
Sulhamstead
Reading
RG7 4BB

Registered number 16173621

Statement of Financial Position

As at 31 March 2026
Notes
2026
£
£
Current assets
Debtors
4,096
4,096
Creditors
Amounts falling due within one year
(13,781)
(13,781)
Net current assets (liabilities)
(9,685)
Total assets less current liabilities
(9,685)
Creditors
Amounts falling due after one year
(15,933)
(15,933)
Net assets (liabilities)
(25,618)
Capital and reserves
Profit and loss account
(25,618)
Total equity
(25,618)

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 6 October 2026 and are signed on its behalf by:

Clarkin, Nicholas Charles Graham
Clarkin, Nicholas Charles Graham
Director

Company registration number 16173621

Notes to the Financial Statements

For the period 9 January 2025 to 31 March 2026

1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

2.2. Going concern

The financial statements have been prepared on a going concern basis. The directors have considered the companys financial position, including negative net assets, and are satisfied that ongoing support and future trading activity will enable the company to meet its obligations.

2.3. Turnover

Revenue is recognised when services are delivered to clients and the company has transferred control of those services. Consultancy revenue is recognised over time as work is performed. Technology platform revenue is recognised when access or deployment services are provided.

2.4. Intangible assets and amortisation

Research and development

Expenditure on research and development is expensed as incurred unless the criteria for capitalisation under FRS 102 are met. Capitalised development costs are amortised over their useful economic life

2.5. Financial instruments

Election and recognition

Financial assets and liabilities are measured at amortised cost unless otherwise stated.

2.6. Trade and other debtors

Debtors are recognised at transaction price less impairment.

2.7. Trade and other creditors

Creditors are recognised at transaction price.

3. Judgements and key sources of estimation uncertainty

Going Concern

The financial statements have been prepared on a going concern basis. The company had net liabilities of £25,618 at 31 March 2026. The directors have confirmed they will continue to provide financial support to the company and will not demand repayment of their loan of £15,933.38 within 12 months of the approval of these financial statements. Based on this support and expected future trading activity, the directors consider it appropriate to prepare the financial statements on a going concern basis.

4. Employees

The average number of employees during the year was 0.

5. Share capital

The company has issued 20 Ordinary shares of £0.01 each, giving a total issued share capital of £0.20.

The shareholdings at 31 March 2026 were as follows:

  • Nicholas Clarkin 10 Ordinary shares
    (including 2 shares transferred on 16 June 2025)
  • Emma WalshWaring 10 Ordinary shares
    (including 2 shares transferred on 16 June 2025)
  • Sildi Jasharaj 0 Ordinary shares
    (previously held 4 shares, transferred on 16 June 2025)

All Ordinary shares carry equal voting rights and dividend rights.

6. Research and Development

The company continued development of its proprietary technology platform, Pulse+, during the period. Pulse+ is designed to unify a clients sales, marketing and customer service technology stack into a single live platform, providing oversight, control and automation tailored to each clients needs.

Development activity during the period included enhancements to automation logic, expansion of industry specific variants, improvements to data management and analytics, integration work across multichannel marketing systems, and infrastructure improvements to support scalability.

All development expenditure was expensed as incurred.

7. Directors’ Loan Account

At 31 March 2026, the company owed £15,933.38 to a director. This balance comprises a combination of cash introduced to support the companys working capital and amounts owed to the director for consultancy services provided to the company. The loan is unsecured, interest free, and repayable on demand.

The directors have confirmed they will not seek repayment of this balance within 12 months of the approval of these financial statements. This financial support has been taken into account when assessing the companys ability to continue as a going concern.